The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1Fathima Zumla Cader, Paul G. Murray, Martina Vockerodt et al.|Blood|2013Cited by 90
Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statementSarah P. Blagden, A. Yiangou, Lucinda Billingham et al.|British Journal of Cancer|2020Cited by 44
The Care of Children With Cancer During the COVID-19 PandemicDaniel C. Moreira, Douglas S. Hawkins, Gerard Millen et al.|American Society of Clinical Oncology Educational Book|2021Cited by 31
The Global COVID‐19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude GlobalDaniel C. Moreira, Carlos Rodríguez‐Galindo, Nickhill Bhakta et al.|Pediatric Blood & Cancer|2021Cited by 16
Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1Victoria Weston, Pamela Kearns|Experimental Hematology|2018Cited by 12